TNXP – Tonix Pharmaceuticals Holding Corp.

TNXP — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

18.46

Margin Of Safety %

Put/Call OI Ratio

0.56

EPS Next Q Diff

1.91

EPS Last/This Y

7.62

EPS This/Next Y

1.8

Price

12.87

Target Price

54.33

Analyst Recom

Performance Q

-23.26

Upside

-3,975.0%

Beta

1.74

Ticker: TNXP

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-02-27	TNXP	13.98	0.25	1.48	3356
2026-03-02	TNXP	13.97	0.29	0.05	3547
2026-03-03	TNXP	13.97	0.29	0.33	3581
2026-03-04	TNXP	13.99	0.29	0.51	3596
2026-03-05	TNXP	13.7	0.31	0.08	3653
2026-03-06	TNXP	13.42	0.31	0.14	3678
2026-03-09	TNXP	13.98	0.30	0.82	3750
2026-03-10	TNXP	14.15	0.30	0.01	3674
2026-03-11	TNXP	13.97	0.29	0.06	3730
2026-03-12	TNXP	13.44	0.29	0.45	3754
2026-03-13	TNXP	13.41	0.29	0.42	3754
2026-03-17	TNXP	14.95	0.28	0.24	3945
2026-03-18	TNXP	14.18	0.28	0.86	4115
2026-03-19	TNXP	15.73	0.30	0.07	4159
2026-03-20	TNXP	14.99	0.29	0.11	4197
2026-03-23	TNXP	15.96	0.24	0.68	1848
2026-03-24	TNXP	15.36	0.37	1.50	2698
2026-03-25	TNXP	15.04	0.43	0.76	2970
2026-03-26	TNXP	13.76	0.44	1.61	3007
2026-03-27	TNXP	12.88	0.56	0.62	3253
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-02-27	TNXP	13.98	71.1	-	-13.25
2026-03-02	TNXP	13.99	71.1	-	-13.25
2026-03-03	TNXP	13.93	71.1	-	-13.25
2026-03-04	TNXP	14.01	71.1	-	-13.25
2026-03-05	TNXP	13.73	71.1	-	-13.25
2026-03-06	TNXP	13.42	71.1	-	-13.25
2026-03-09	TNXP	13.95	71.1	-	-13.25
2026-03-10	TNXP	14.16	71.1	-	-13.25
2026-03-11	TNXP	13.98	71.1	-	-13.25
2026-03-12	TNXP	13.45	71.1	-	-13.25
2026-03-13	TNXP	13.27	71.1	-	-13.25
2026-03-17	TNXP	15.00	71.1	-	-13.25
2026-03-18	TNXP	14.20	71.1	-	-13.25
2026-03-19	TNXP	15.76	71.1	-	-13.25
2026-03-20	TNXP	14.99	3.5	-	-8.60
2026-03-23	TNXP	16.06	-	-	-6.95
2026-03-24	TNXP	15.35	-	-	-6.95
2026-03-25	TNXP	15.01	-	-	-6.95
2026-03-26	TNXP	13.76	-	-	-6.95
2026-03-27	TNXP	12.87	-	-	-6.95
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-02-27	TNXP	0.00	11.91	18.43
2026-03-02	TNXP	0.00	12.23	18.43
2026-03-03	TNXP	0.00	0	0
2026-03-04	TNXP	0	0	18.43
2026-03-05	TNXP	0.00	0	18.43
2026-03-06	TNXP	0.00	0	18.43
2026-03-09	TNXP	0.00	12.24	18.43
2026-03-10	TNXP	0.00	12.24	18.43
2026-03-11	TNXP	0.00	12.24	16.46
2026-03-12	TNXP	0.00	12.24	16.46
2026-03-13	TNXP	0.00	12.24	16.46
2026-03-17	TNXP	0.00	11.61	15.70
2026-03-18	TNXP	0.00	11.61	15.70
2026-03-19	TNXP	223.80	11.61	15.70
2026-03-20	TNXP	223.79	11.61	15.70
2026-03-23	TNXP	223.79	11.68	15.70
2026-03-24	TNXP	223.79	11.68	15.70
2026-03-25	TNXP	223.79	11.68	18.46
2026-03-26	TNXP	223.79	11.68	18.46
2026-03-27	TNXP	223.79	11.68	18.46
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-3.98

Avg. EPS Est. Current Quarter

-2.06

Avg. EPS Est. Next Quarter

-2.07

Insider Transactions

223.79

Institutional Transactions

11.68

Beta

1.74

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

100

Max Drawdown 5-Year %

-100

Target Price

54.33

P/E

Forward P/E

PEG

P/S

13.17

P/B

0.67

P/Free Cash Flow

EPS

-14.26

Average EPS Est. Cur. Y

-6.95

EPS Next Y. (Est.)

-5.15

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-946.22

Relative Volume

1.84

Return on Equity vs Sector %

-77.9

Return on Equity vs Industry %

-61.7

EPS 1 7Days Diff

1.7

EPS 1 30Days Diff

1.65

EBIT Estimation

◆ TNXP Healthcare

$12.88

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

14/20

Pullback

15/25

Volume

3/15

Valuation

12/20

TP/AR

2/10

Options

5/10

RSI

39.6

Range 1M

5.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

10/25

Growth

24/30

Estimates

2/20

Inst/Vol

8/15

Options

8/10

EPS Yr

36.3%

EPS NY

52.3%

52W%

0.4%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +321.8% upside

Quality

5/30

Valuation

16/30

Growth

18/25

Stability

7/10

LT Trend

4/5

Upside

+321.8%

Quality

Tonix Pharmaceuticals Holding C

Sector: Healthcare

Industry: Biotechnology

Employees: 142

Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States. The company offers TONMYA, a cyclobenzaprine HCl sublingual tablet for the treatment of fibromyalgia. It also markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. In addition, the company develops TNX-102 SL, a cyclobenzaprine HCl sublingual tablet for the treatment of major depressive disorder and acute stress reaction/acute stress disorder; TNX-1300, a double-mutant cocaine esterase for the treatment of cocaine intoxication; TNX-1500, an Fc-modified humanized monoclonal antibody to prevent kidney transplant rejection, as well as to treat autoimmune conditions; TNX-4800, a humanized monoclonal antibody for the seasonal prevention of Lyme disease; and TNX-2900, an intranasal oxytocin potentiated with magnesium for the treatment of Prader-Willi syndrome. Further, it is developing TNX-1900, an intranasal potentiated oxytocin for the treatment of binge eating disorder, adolescent obesity, and bone health in pediatric autism, and arginine-vasopressin deficiency; TNX-801, a live horsepox vaccine for the prevention of smallpox and mpox; TNX-4200, a small molecule broad-spectrum antiviral agent targeting CD45 for the treatment or prevention of viral disease; TNX-4900, a highly selective small-molecule Sigma-1 receptor antagonist for neuropathic pain; TNX-1700, a recombinant Trefoil Factor Family 2 fusion protein for the treatment of gastric and colorectal cancers; and TNX-1800 and TNX-1850, live modified horsepox vaccines for the prevention of COVID. Tonix Pharmaceuticals Holding Corp. was founded in 2007 and is based in Berkeley Heights, New Jersey.

TNXP

Latest News

—

Caricamento notizie per TNXP…

stock quote shares TNXP – Tonix Pharmaceuticals Holding Corp. Stock Price stock today

news today TNXP – Tonix Pharmaceuticals Holding Corp. stock forecast ,stock prediction 2023 2024 2025

marketwatch TNXP – Tonix Pharmaceuticals Holding Corp. yahoo finance google finance

stock history TNXP – Tonix Pharmaceuticals Holding Corp. invest stock market

stock prices TNXP premarket after hours

ticker TNXP fair value insiders trading

TNXP – Tonix Pharmaceuticals Holding Corp.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: TNXP

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y